Regulation of the transcriptional activity of the nuclear factor-κB p65 subunit

Biochemical Pharmacology

Volumn 64, Issue 5-6, 2002, Pages 963-970

  Vermeulen, Linda ^a   De Wilde, Gert ^a   Notebaert, Sofie ^a   Vanden Berghe, Wim ^a   Haegeman, Guy ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Gene regulation; Histone modification; MSK; NF B; Phosphorylation; Transcriptional activity

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; PROTEIN SUBUNIT; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOTAGMIN; WORTMANNIN;

ACETYLATION; APOPTOSIS; ARTICLE; CELL DIVISION; CELLULAR DISTRIBUTION; CHROMATIN; CYTOPLASM; GENE ACTIVATION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; METHYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; EIF-2 KINASE; GENE EXPRESSION REGULATION; HUMANS; NF-KAPPA B; PHOSPHORYLATION; PROTEIN SUBUNITS; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; TRANS-ACTIVATION (GENETICS);

EID: 0036710479     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)01161-9     Document Type: Article

References (85)

1. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: The control of NF-κB activity. Annu. Rev. Immunol. 18:2000;621-663.
2. Perkins N.D. The Rel/NF-κB family: Friend and foe. Trends Biochem. Sci. 25:2000;434-440.
3. Pahl H.L. Activators and target genes of Rel/NF-κB transcription factors. Oncogene. 18:1999;6853-6866.
4. Gilmore T.D. The Rel/NF-κB signal transduction pathway: Introduction. Oncogene. 18:1999;6842-6844.
5. Malek S., Chen Y., Huxford T., Ghosh G. IκBβ but not IκBα functions as a classical cytoplasmic inhibitor of NF-κB dimers by masking both NF-κB nuclear localization sequences in resting cells. J. Biol. Chem. 276:2001;45225-45235.
6. Tam W.F., Sen R. IκB family members function by different mechanisms. J. Biol. Chem. 276:2001;7701-7704.
7. Johnson C., Van Antwerp D., Hope T.J. An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IκBα EMBO J. 18:1999;6682-6693.
8. Huang T.T., Kudo N., Yoshida M., Miyamoto S. A nuclear export signal in the N-terminal regulatory domain of IκBα controls cytoplasmic localization of inactive NF-κB/IκBα complexes. Proc. Natl. Acad. Sci. U.S.A. 97:2000;1014-1019.
9. Israel A. The IKK complex: An integrator of all signals that activate NF-κB? Trends Cell Biol. 10:2000;129-133.
10. Karin M. How NF-κB is activated: The role of the IκB kinase (IKK) complex. Oncogene. 18:1999;6867-6874.
11. Schmitz M.L., Bacher S., Kracht M. IκB-independent control of NF-κB activity by modulatory phosphorylations. Trends Biochem. Sci. 26:2001;186-190.
12. Wang D., Baldwin A.S. Jr. Activation of nuclear factor-κB-dependent transcription by tumor necrosis factor-α is mediated through phosphorylation of RelA/p65 on serine 529. J. Biol. Chem. 273:1998;29411-29416.
13. Wang D., Westerheide S.D., Hanson J.L., Baldwin A.S. Jr. Tumor necrosis factor α-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II. J. Biol. Chem. 275:2000;32592-32597.
14. Bird T.A., Schooley K., Dower S.K., Hagen H., Virca G.D. Activation of nuclear transcription factor NF-κB by interleukin-1 is accompanied by casein kinase II-mediated phosphorylation of the p65 subunit. J. Biol. Chem. 272:1997;32606-32612.
15. Sakurai H., Chiba H., Miyoshi H., Sugita T., Toriumi W. IκB kinases phosphorylate NF-κB p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 274:1999;30353-30356.
16. Schmitz M.L., dos Santos Silva M.A., Baeuerle P.A. Transactivation domain 2 (TA2) of p65 NF-κB: Similarity to TA1 and phorbol ester-stimulated activity and phosphorylation in intact cells. J. Biol. Chem. 270:1995;15576-15584.
17. 2+/calmodulin-dependent protein kinase IV stimulates nuclear factor-κB transactivation via phosphorylation of the p65 subunit. J. Biol. Chem. 276:2001;20005-20010.
18. Zhong H., SuYang H., Erdjument Bromage H., Tempst P., Ghosh S. The transcriptional activity of NF-κB is regulated by the IκB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell. 89:1997;413-424.
19. ras and protein kinase Cζ in primary endothelial cells. J. Biol. Chem. 274:1999;13594-13603.
20. Leitges M., Sanz L., Martin P., Duran A., Braun U., Garcia J.F., Camacho F., Diaz-Meco M.T., Rennert P.D., Moscat J. Targeted disruption of the ζPKC gene results in the impairment of the NF-κB pathway. Mol. Cell. 8:2001;771-780.
21. Yang J., Fan G.H., Wadzinski B.E., Sakurai H., Richmond A. Protein phosphatase 2A interacts with and directly dephosphorylates RelA. J. Biol. Chem. 276:2001;47828-47833.
22. Ashburner B.P., Westerheide S.D., Baldwin A.S. Jr. The p65 (RelA) subunit of NF-κB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol. Cell Biol. 21:2001;7065-7077.
23. Chen L., Fischle W., Verdin E., Greene W.C. Duration of nuclear NF-κB action regulated by reversible acetylation. Science. 293:2001;1653-1657.
24. Ozes O.N., Mayo L.D., Gustin J.A., Pfeffer S.R., Pfeffer L.M., Donner D.B. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature. 401:1999;82-85.
25. Kane L.P., Shapiro V.S., Stokoe D., Weiss A. Induction of NF-κB by the Akt/PKB kinase. Curr. Biol. 9:1999;601-604.
26. Manna S.K., Aggarwal B.B. Wortmannin inhibits activation of nuclear transcription factors NF-κB and activated protein-1 induced by lipopolysaccharide and phorbol ester. FEBS Lett. 473:2000;113-118.
27. Sizemore N., Leung S., Stark G.R. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-κB p65/RelA subunit. Mol. Cell Biol. 19:1999;4798-4805.
28. Madrid L.V., Wang C.Y., Guttridge D.C., Schottelius A.J., Baldwin A.S. Jr., Mayo M.W. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-κB. Mol. Cell Biol. 20:2000;1626-1638.
29. Madrid L.V., Mayo M.W., Reuther J.Y., Baldwin A.S. Jr. Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-κB through utilization of the IκB kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem. 276:2001;18934-18940.
30. Sizemore N., Lerner N., Dombrowski N., Sakuria H., Stark G.R. Distinct roles of the IκB kinase a and b subunits in liberating NF-κB from IκB and in phosphorylating the p65 subunit of NF-κB. J. Biol. Chem. 277:2002;3863-3869.
31. Delhase M., Li N., Karin M. Kinase regulation in inflammatory response. Nature. 406:2000;367-368.
32. Madge L.A., Pober J.S. A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1 inhibits apoptosis but does not activate NF-κB in human endothelial cells. J. Biol. Chem. 275:2000;15458-15465.
33. Rauch B.H., Weber A., Braun M., Zimmermann N., Schror K. PDGF-induced Akt phosphorylation does not activate NF-κB in human vascular smooth muscle cells and fibroblasts. FEBS Lett. 481:2000;3-7.
34. Zhong H., Voll R.E., Ghosh S. Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell. 1:1998;661-671.
35. Deak M., Clifton A.D., Lucocq L.M., Alessi D.R. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38 and may mediate activation of CREB. EMBO J. 17:1998;4426-4441.
36. Thomson S., Clayton A.L., Hazzalin C.A., Rose S., Barratt M.J., Mahadevan L.C. The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG-14 kinase. EMBO J. 18:1999;4779-4793.
37. Pierrat B., Correia J.S., Mary J.L., Tomas Zuber M., Lesslauer W. RSK-B a novel ribosomal S6 kinase family member is a CREB kinase under dominant control of p38α mitogen-activated protein kinase (p38αMAPK). J. Biol. Chem. 273:1998;29661-29671.
38. Tomas-Zuber M., Mary J.L., Lesslauer W. Control sites of ribosomal S6 kinase B and persistent activation through tumor necrosis factor. J. Biol. Chem. 275:2000;23549-23558.
39. Kwok R.P., Lundblad J.R., Chrivia J.C., Richards J.P., Bachinger H.P., Brennan R.G., Roberts S.G., Green M.R., Goodman R.H. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature. 370:1994;223-236.
40. Chrivia J.C., Kwok R.P., Lamb N., Hagiwara M., Montminy M.R., Goodman R.H. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature. 365:1993;855-859.
41. Parker D., Ferreri K., Nakajima T., LaMorte V.J., Evans R., Koerber S.C., Hoeger C., Montminy M.R. Phosphorylation of CREB at Ser-133 induces complex formation with CREB-binding protein via a direct mechanism. Mol. Cell Biol. 16:1996;694-703.
42. Radhakrishnan I., Perez Alvarado G.C., Parker D., Dyson H.J., Montminy M.R., Wright P.E. Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: A model for activator:coactivator interactions. Cell. 91:1997;741-752.
43. Kee B.L., Arias J., Montminy M.R. Adaptor-mediated recruitment of RNA polymerase II to a signal-dependent activator. J. Biol. Chem. 271:1996;2373-2375.
44. Nakajima T., Uchida C., Anderson S.F., Parvin J.D., Montminy M. Analysis of a cAMP-responsive activator reveals a two-component mechanism for transcriptional induction via signal-dependent factors. Genes Dev. 11:1997;738-747.
45. Korzus E., Torchia J., Rose D.W., Xu L., Kurokawa R., McInerney E.M., Mullen T.M., Glass C.K., Rosenfeld M.G. Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science. 279:1998;703-707.
46. Martinez-Balbas M.A., Bannister A.J., Martin K., Haus-Seuffert P., Meisterernst M., Kouzarides T. The acetyltransferase activity of CBP stimulates transcription. EMBO J. 17:1998;2886-2893.
47. Ogryzko V.V., Schiltz R.L., Russanova V., Howard B.H., Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell. 87:1996;953-959.
48. Zhang Y., Liu G., Dong Z. MSK1 and JNKs mediate phosphorylation of STAT3 in UVA-irradiated mouse epidermal JB6 cells. J. Biol. Chem. 276:2001;42534-42542.
49. Nomura M., Kaji A., Ma W.Y., Zhong S., Liu G., Bowden G.T., Miyamoto K.I., Dong Z. Mitogen- and stress-activated protein kinase 1 mediates activation of Akt by ultraviolet B irradiation. J. Biol. Chem. 276:2001;25558-25567.
50. Barratt M.J., Hazzalin C.A., Cano E., Mahadevan L.C. Mitogen-stimulated phosphorylation of histone H3 is targeted to a small hyperacetylation-sensitive fraction. Proc. Natl. Acad. Sci. U.S.A. 91:1994;4781-4785.
51. Cheung P., Tanner K.G., Cheung W.L., Sassone-Corsi P., Denu J.M., Allis C.D. Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. Mol. Cell. 5:2000;905-915.
52. Lo W.S., Trievel R.C., Rojas J.R., Duggan L., Hsu J.Y., Allis C.D., Marmorstein R., Berger S.L. Phosphorylation of serine 10 in histone H3 is functionally linked in vitro and in vivo to Gcn5-mediated acetylation at lysine 14. Mol. Cell. 5:2000;917-926.
53. Thomson S., Clayton A.L., Mahadevan L.C. Independent dynamic regulation of histone phosphorylation and acetylation during immediate-early gene induction. Mol. Cell. 8:2001;1231-1241.
54. Jenuwein T., Allis C.D. Translating the histone code. Science. 293:2001;1074-1080.
55. Wolffe A.P., Hayes J.J. Chromatin disruption and modification. Nucl. Acids Res. 27:1999;711-720.
56. Cheung P., Allis C.D., Sassone-Corsi P. Signaling to chromatin through histone modifications. Cell. 103:2000;263-271.
57. Strahl B.D., Allis C.D. The language of covalent histone modifications. Nature. 403:2000;41-45.
58. Mayr B., Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2:2001;599-609.
59. Mayr B.M., Canettieri G., Montminy M.R. Distinct effects of cAMP and mitogenic signals on CREB-binding protein recruitment impart specificity to target gene activation via CREB. Proc. Natl. Acad. Sci. U.S.A. 98:2001;10936-10941.
60. Xu W., Chen H., Du K., Asahara H., Tini M., Emerson B.M., Montminy M., Evans R.M. A transcriptional switch mediated by cofactor methylation. Science. 294:2001;2507-2511.
61. Asahara H., Santoso B., Guzman E., Du K., Cole P.A., Davidson I., Montminy M. Chromatin-dependent cooperativity between constitutive and inducible activation domains in CREB. Mol. Cell. Biol. 21:2001;7892-7900.
62. Seo S.B., McNamara P., Heo S., Turner A., Lane W.S., Chakravarti D. Regulation of histone acetylation and transcription by INHAT a human cellular complex containing the set oncoprotein. Cell. 104:2001;119-130.
63. Senger K., Merika M., Agalioti T., Yie J., Escalante R.C., Chen G., Aggarwal K.A., Thanos D. Gene repression by coactivator repulsion. Mol. Cell. 6:2000;931-937.
64. Michael L.F., Asahara H., Shulman A.I., Kraus W.L., Montminy M. The phosphorylation status of a cyclic AMP-responsive activator is modulated via a chromatin-dependent mechanism. Mol. Cell Biol. 20:2000;1596-1603.
65. Boisvert F.M., Kruhlak M.J., Box A.K., Hendzel M.J., Bazett-Jones D.P. The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body. J. Cell Biol. 152:2001;1099-1106.
66. Doucas V. The promyelocytic (PML) nuclear compartment and transcription control. Biochem. Pharmacol. 60:2000;1197-1201.
67. von Mikecz A., Zhang S., Montminy M., Tan E.M., Hemmerich P. CREB-binding protein (CBP)/p300 and RNA polymerase II colocalize in transcriptionally active domains in the nucleus. J. Cell Biol. 150:2000;265-273.
68. Carmo-Fonseca M. The contribution of nuclear compartimentalization to gene regulation. Cell. 108:2002;513-521.
69. Francastel C., Schubeler D., Martin D.I., Groudine M. Nuclear compartmentalization and gene activity. Nat. Rev. Mol. Cell Biol. 1:2000;137-143.
70. Stenoien D.L., Simeoni S., Sharp Z.D., Mancini M.A. Subnuclear dynamics and transcription factor function. J. Cell Biochem. Suppl. 1:2000;99-106.
71. Hodges M., Tissot C., Freemont P.S. Protein regulation: Tag wrestling with relatives of ubiquitin. Curr. Biol. 8:1998;R749-752.
72. Merienne K., Pannetier S., Harel-Bellan A., Sassone-Corsi P. Mitogen-regulated RSK2-CBP interaction controls their kinase and acetylase activities. Mol. Cell Biol. 21:2001;7089-7096.
73. Hazzalin C.A., Mahadevan L.C. Transcription MAPK-regulated transcription: A continuously variable gene switch? Nat. Rev. Mol. Cell Biol. 3:2002;30-40.
74. Krueger J.S., Keshamouni V.G., Atanaskova N., Reddy K.B. Temporal and quantitative regulation of mitogen-activated protein kinase (MAPK) modulates cell motility and invasion. Oncogene. 20:2001;4209-4218.
75. Wu G.Y., Deisseroth K., Tsien R.W. Activity-dependent CREB phosphorylation: Convergence of a fast, sensitive calmodulin kinase pathway and a slow, less sensitive mitogen-activated protein kinase pathway. Proc. Natl. Acad. Sci. U.S.A. 98:2001;2808-2813.
76. Levchenko A., Bruck J., Sternberg P.W. Scaffold proteins may biphasically affect the levels of mitogen-activated protein kinase signaling and reduce its threshold properties. Proc. Natl. Acad. Sci. U.S.A. 97:2000;5818-5823.
77. Drier E.A., Huang L.H., Steward R. Nuclear import of the Drosophila Rel protein dorsal is regulated by phosphorylation. Genes Dev. 13:1999;556-568.
78. West M.J., Lowe A.D., Karn J. Activation of human immunodeficiency virus transcription in T cells revisited: NF-κB p65 stimulates transcriptional elongation. J. Virol. 75:2001;8524-8537.
79. Kim J.H., Lane W.S., Reinberg D. Human elongator facilitates RNA polymerase II transcription through chromatin. Proc. Natl. Acad. Sci. U.S.A. 99:2002;1241-1246.
80. Weinmann A.S., Mitchell D.M., Sanjabi S., Bradley M.N., Hoffmann A., Liou H.C., Smale S.T. Nucleosome remodeling at the IL-12 p40 promoter is a TLR-dependent Rel-independent event. Nat. Immunol. 2:2001;51-57.
81. Agalioti T., Lomvardas S., Parekh B., Yie J., Maniatis T., Thanos D. Ordered recruitment of chromatin modifying and general transcription factors to the IFN-β promoter. Cell. 103:2000;667-678.
82. Parekh B.S., Maniatis T. Virus infection leads to localized hyperacetylation of histones H3 and H4 at the IFN-β promoter. Mol. Cell. 3:1999;125-129.
83. Saccani S., Pantano S., Natoli G. Two waves of nuclear factor κB recruitment to target promoters. J. Exp. Med. 193:2001;1351-1359.
84. Saccani S., Pantano S., Natoli G. p38-dependent marking of inflammatory genes for increased NF-κB recruitment. Nat. Immunol. 3:2002;69-75.
85. Plaisance S., Vanden Berghe W., Boone E., Fiers W., Haegeman G. Recombination signal sequence binding protein Jκ is constitutively bound to the NF-κB site of the interleukin-6 promoter and acts as a negative regulatory factor. Mol. Cell Biol. 17:1997;3733-3743.